Literature DB >> 24711312

How are we going to live with Alzheimer's disease?

Jason Karlawish.   

Abstract

Alzheimer's disease confronts us with an ethical challenge: How do we live with dignity and quality of life in the face of progressive disability and, ultimately, death? Patients' cognitive and decision-making impairments often make them unable to answer this question, and when professionals who provide services for older adults fail to recognize and accommodate these impairments, patients suffer. Patients and their caregivers need a health care system that fosters caregiving so that each will live with dignity and well-being. Another way to answer this question is to discover treatments that prevent disabling cognitive impairments, but this strategy will require expanding the Alzheimer's label to include people who do not have dementia or who are even cognitively normal. Controversies are likely to occur over how best to describe the Alzheimer's problem, measure the value of early diagnosis and treatment, and live with a brain at risk.

Entities:  

Keywords:  Elderly; Ethical Issues; Legal/Regulatory Issues

Mesh:

Year:  2014        PMID: 24711312      PMCID: PMC4349350          DOI: 10.1377/hlthaff.2014.0089

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  25 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 4.  Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis.

Authors:  Martin Pinquart; Silvia Sörensen
Journal:  Psychol Aging       Date:  2003-06

5.  Care partners and online patient portals.

Authors:  Urmimala Sarkar; David W Bates
Journal:  JAMA       Date:  2014 Jan 22-29       Impact factor: 56.272

6.  Changing concepts of Alzheimer disease.

Authors:  Guy M McKhann
Journal:  JAMA       Date:  2011-06-15       Impact factor: 56.272

7.  Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease.

Authors:  Jason Karlawish
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

8.  Caregiving as moral experience.

Authors:  Arthur Kleinman
Journal:  Lancet       Date:  2012-11-03       Impact factor: 79.321

9.  From illness as culture to caregiving as moral experience.

Authors:  Arthur Kleinman
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

Review 10.  Preclinical Alzheimer disease-the challenges ahead.

Authors:  Reisa A Sperling; Jason Karlawish; Keith A Johnson
Journal:  Nat Rev Neurol       Date:  2012-11-27       Impact factor: 42.937

View more
  2 in total

1.  The Paradox of Scarcity in a Land of Plenty: Meeting the Needs of Older Adults with Mental Health and Substance Use Disorders.

Authors:  Stephen J Bartels; Renee Pepin; Lydia E Gill
Journal:  Generations       Date:  2014

2.  Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease.

Authors:  Massimo S Fiandaca; Xiaogang Zhong; Amrita K Cheema; Michael H Orquiza; Swathi Chidambaram; Ming T Tan; Carole Roan Gresenz; Kevin T FitzGerald; Mike A Nalls; Andrew B Singleton; Mark Mapstone; Howard J Federoff
Journal:  Front Neurol       Date:  2015-11-12       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.